Rolapitant

Rolapitant is a medication used to prevent nausea and vomiting caused by chemotherapy treatments in cancer patients. It works by blocking a specific receptor (a type of protein) in the brain called the NK-1 receptor, which is involved in triggering the nausea response. By inhibiting this receptor, rolapitant helps reduce the likelihood of these side effects, allowing patients to better tolerate their chemotherapy sessions. It is typically taken as a tablet before chemotherapy and is often used alongside other anti-nausea medicines for improved effectiveness.